Alentis Therapeutics vs ImmunoGen
Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
73 employees · est. 2019 · Allschwil, Switzerland
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need
34 employees · est. 1981
ImmunoGen is the older company (2019 vs 1981); Alentis Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Alentis Therapeutics | ImmunoGen |
|---|---|---|
| Founded | ||
| Founded | 2019 | 1981 older |
| Headquarters | ||
| Headquarters | Allschwil, Switzerland | Not tracked yet |
| Employees | ||
| Employees | 73 larger | 34 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series D | Acquired |
| Total Funding | ||
| Total Funding | $364.50M | $681.30M |
| Funding Rounds | ||
| Funding Rounds | 4 | 11 |
| Services | ||
| Services | Development of anti-Claudin-1 ADCs, Clinical trials for monoclonal antibodies, Fibrosis study results publication, Leadership in therapeutic development | Drug Development, Clinical Trials Management, Cancer Research and Treatment Solutions, Healthcare Professional Support |
| Target Customers | ||
| Target Customers | Cancer patients, Patients with organ fibrosis, Healthcare professionals, Biotech investors | Cancer Patients, Oncologists, Healthcare Providers, Research Institutions |
| Taxonomy | ||
| Taxonomy | Claudin-1Tumor TreatmentOrgan FibrosisAntibody-drug ConjugatesOncologyLiver Fibrosis +9 | Antibody-drug ConjugatesCancer TreatmentOncologyImmunologyNeuroscienceTherapeutics Development +6 |
| Website | ||
| Website | alentis.ch | immunogen.com |
About Alentis Therapeutics
Alentis Therapeutics, founded in 2019, is a pioneering clinical-stage biotechnology company with a focus on developing breakthrough treatments for Claudin1-positive tumors and organ fibrosis. The company is based in the pharma-biotech hub of Basel, Switzerland. The company specializes in first-in-c...
About ImmunoGen
ImmunoGen, Inc. is a biotechnology innovator, harnessing the potential of antibody-drug conjugates (ADCs) to revolutionize cancer treatment. With a focus on oncology, the company combines the precision of antibodies with the effectiveness of cytotoxic drugs, aiming to target cancer cells while spari...
Also comparing in this category
Comparing more than these two?
Get Alentis Therapeutics, ImmunoGen and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Alentis Therapeutics compare?
A PDF of Alentis Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Alentis Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Alentis Therapeutics on 28 Jan 2026, and ImmunoGen on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
